Qualitest Pharmaceuticals, Inc., is recalling all lots of its Accusure Insulin Syringes, a type of syringe used to deliver insulin to patients with diabetes, because the syringes have been found to have needles that can detach from the syringe. When the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after injection. The recall expands on an August recall of specific lots of Accusure Insulin Syringes for the same detaching needle issue, to cover all lots of Accusure Insulin Syringes.

The distributed syringes are of the following descriptions and NDC numbers: 28G 1/2cc, NDC 0603-6995-21;28G 1cc, NDC 0603-6996-21; 29G 1/2cc NDC 0603-6997-21, 29G 1cc, NDC 0603-6998-21, 30G 1/2cc, NDC 0603-999-21, 30G 1cc, NDC 0603-7000-21, 31G 1/2cc, NDC 0603-7001-21; and 31G 1cc, NDC 0603-7002-21. All Accusure Insulin Syringes regardless of lot number are subject to this recall. These syringes were distributed between January 2002 and October 2009 to wholesale and retail pharmacies nationwide (including Puerto Rico). The syringes in these lots may have needles which detach from the syringe.

Consumers who have any Accusure Insulin Syringes should stop using them and call Qualitest at 800-444-4011 for reimbursement. Any adverse events or problems experienced while using this product should be reported to the Food and Drug Administration’s MedWatch Adverse Event program at www.fda.gov/medwatch/report.htm.

Related posts:

1. Insulin syringes recalled; may pose risk to patients
2. Recalled insulin syringes may be mislabeled
3. FDA reminds public to inspect supply of insulin for stolen, tainted vials
4. Possible insulin pump defect sparks FDA recall
5. Powdered dietary supplements recalled for Salmonella contamination